NADLT vs Sodium Caprylate: A Stabilizer Comparison for Albumin Manufacturing

23-07-2026

Quick answer: NADLT (N-Acetyl-DL-Tryptophan) and sodium caprylate are the two industry-standard stabilizers used together in pharmaceutical-grade human serum albumin to protect the protein during heat treatment for viral inactivation. Research shows sodium caprylate alone is generally more effective at equivalent molar concentrations than NADLT alone, but the combination of both provides better thermal stabilization than either used individually which is why virtually all commercial albumin formulations use both rather than choosing one over the other.

Formulators and procurement teams working on human serum albumin or other blood-derived protein products inevitably encounter both NADLT and sodium caprylate, since pharmaceutical-grade HSA contains both stabilizers sodium caprylate and N-acetyltryptophanate to protect the protein from oxidative stress and stabilize it for heat treatment. Understanding how the two compare, rather than treating them as interchangeable alternatives, is essential for both formulation and sourcing decisions.

Mechanism and chemical class

NADLT is a synthetic derivative of the amino acid tryptophan, acetylated at the nitrogen position. Sodium caprylate is the sodium salt of caprylic acid (octanoic acid), a medium-chain fatty acid. The two compounds are chemically unrelated one is an amino acid derivative, the other a fatty acid salt but both bind to human serum albumin and, in doing so, help stabilize its structure against the heat-induced polymer formation that would otherwise occur during pasteurization.

Relative effectiveness as stabilizers

Research comparing the two directly found a clear order of stabilizing effectiveness: the combination of caprylate and acetyltryptophanate performed best, closely followed by caprylate alone, which outperformed acetyltryptophanate alone even at double the molar concentration. In practical terms, this means sodium caprylate is the more potent single stabilizer on a molar basis, but NADLT contributes meaningfully to overall stability when used alongside it which is why the combination, rather than either compound alone, is the standard approach in commercial albumin manufacturing.

Effect on albumin's binding capacity

Beyond thermal stabilization, both compounds interact with albumin's binding sites for other substances. Research comparing the two found that, at matched concentrations, albumin binding capacity was lower when caprylate was added than when N-acetyltryptophan was added, suggesting caprylate has a somewhat greater affinity for albumin's binding sites than NADLT does. Separately, both stabilizers have been shown to displace bilirubin from its complex with albumin, an effect that becomes clinically relevant in specific patient populations, such as those with liver disease, where albumin's binding function matters for treatment efficacy.

Sourcing considerations: side-by-side comparison

Factor	NADLT (N-Acetyl-DL-Tryptophan)	Sodium Caprylate
Chemical class	Acetylated amino acid derivative	Medium-chain fatty acid salt
Relative stabilizing potency (per molar concentration)	Lower than caprylate alone	Higher than NADLT alone
Typical use	Combined with sodium caprylate	Combined with NADLT
Compendial monograph status	No established NF monograph; proposed monograph based on validated HPLC methods	More established as a commonly referenced pharmaceutical excipient
Primary buyer base	Biopharma/plasma-product manufacturers	Biopharma/plasma-product manufacturers, plus broader pharmaceutical and nutritional uses
Sourcing complexity	Narrower supplier base given specialty status	Somewhat broader supplier base due to wider general use

Why buyers source both together rather than choosing one

Because the two stabilizers are used in combination in nearly all commercial albumin formulations, procurement for one typically comes with procurement for the other as a paired requirement not a comparison of alternatives to pick between. This is different from, say, comparing two disintegrants where a formulator picks one over the other. For albumin manufacturing, the relevant sourcing question is usually "can this supplier reliably provide both, with matched documentation and quality standards," rather than "which one should I choose."

What this means for procurement teams

If you're sourcing stabilizers for an established albumin formulation, your specification will already call for both compounds at defined ratios the comparison here is informational rather than a live sourcing decision. But for teams evaluating new formulation approaches or benchmarking supplier options, it's worth knowing that NADLT's compendial status is less settled than sodium caprylate's, which means documentation requests (particularly around analytical method reference) may need to be more specific for NADLT than for caprylate.

It's also worth sourcing both stabilizers from suppliers who can demonstrate specific experience with albumin or blood-product stabilization use cases, rather than general specialty chemical suppliers, given how tightly controlled the quality requirements are for both compounds in this application.

Frequently asked questions

Can sodium caprylate be used alone without NADLT in albumin formulations?

Research indicates caprylate alone is more effective than NADLT alone at matched concentrations, and raising caprylate concentration further provided little additional stabilization benefit beyond a certain point but the combination of both compounds outperformed caprylate alone, which is why standard commercial formulations use both together rather than caprylate in isolation.

Is one stabilizer easier to source than the other?

Sodium caprylate generally has a more established compendial and supply history given its broader pharmaceutical and nutritional applications, while NADLT's supplier base is narrower and more specifically tied to biopharma stabilizer use.

Do both stabilizers need to come from the same supplier?

Not necessarily, but sourcing both from a supplier experienced specifically in biopharma stabilizer applications rather than mixing a specialty supplier for one and a general distributor for the other can simplify documentation consistency across your formulation's raw material dossier.

The bottom line

NADLT and sodium caprylate aren't competing options for the same job they're complementary stabilizers used together in virtually all commercial human serum albumin formulations. Sodium caprylate is the more potent individual stabilizer and has a more established compendial history, while NADLT's contribution is essential to the combined stabilization effect that commercial formulations rely on. Sourcing decisions should focus on documentation consistency and supplier experience with this specific application, rather than choosing one compound over the other.

Sourcing both albumin stabilizers for a biopharma formulation? Compare NADLT and sodium caprylate specifications on Clyzo with documentation available for both.

Injectable Excipients N-Acetyl-DL-Tryptophan NADLT Albumin Stabilization Biopharmaceutical Manufacturing Pharmaceutical Grade Plasma Fractionation Protein Stabilization Regulatory Compliance USP Grade

Vaccine Excipients Oral Topical Biopharma

Ethanol 96% v/v for pharmaceutical excipients (Ph.... ... Ethanol 96% v/v for pharmaceutical excipients (Ph.Eur., BP, USP IPEC Grade) | Clyzo Read more

14-08-2026